News Column

Top International Neuroscience Clinicians, Scientists, Industry Leaders Collaborate at Third Annual Targeted Drug Delivery Conference in San Francisco

May 22 2013 12:00AM

Marketwire

LogoTracker

NAPA, CA -- (Marketwired) -- 05/22/13 -- The world's top minds in medicine, science and business convened in San Francisco for the Third Annual Targeted Drug Delivery Conference. The conference provides a venue to stimulate collaboration on innovative treatments for patients suffering from neurological diseases such as Parkinson's, Alzheimer's and chronic pain. Direct delivery of therapies using implanted devices can provide long-term relief and avoid the difficulties in getting oral medications into the nervous system. These implanted devices allow for high concentration of drugs to be delivered directly to a specific site with potentially fewer systemic side effects.

Neurovations, a leading clinical research and consulting company in the fields of pain management and neuroscience, hosted the three-day long conference at San Francisco's InterContinental Mark Hopkins Hotel. It is the only meeting of its kind to bring together top clinicians, scientists and economic industry leaders from around the world to discuss the future of these promising treatments.

"The annual forum helps shorten the time between generating scientific ideas and the patient actually receiving therapy based on those ideas," said Neurovations founder and president Eric Grigsby, MD, MBA. "The purpose is to break down the walls between scientific discovery, financial realities, regulatory hurdles and market competition to foster collaboration that builds a swift path to market and ultimately patient treatment."

The forum featured discussions about the future of therapeutic agents delivered directly to the brain and spinal cord. Developing devices and techniques to deliver medication directly to the neurologic target represents a promising opportunity to treat difficult conditions including chronic pain and other neurologic diseases.

Other conference highlights:

Krys Bankiewicz, MD, PhD of the Department of Neurological Surgery at the University of California, San Francisco shared data discovered in direct drug delivery treatment for brain tumors. •Eric Grigsby, MD, MBA (host) led an industry discussion, Surgical Techniques on Pump and Catheter Placement for intrathecal drug delivery. Dr. Grigsby also discussed the economic and operational issues associated with IT infusion in pain management. •Sten G.E. Lindahl, MD, PhD, FRCA, member of the Nobel assembly for the Nobel Prize in Physiology or Medicine (1996 - 2012), led a discussion on the global perspective on medical innovation for countries in extreme poverty. •Russ Lonser, MD, chairman of the Department of Neurological Surgery at Ohio State University, presented his data on how to deliver drugs directly to the brain for patients with diseases such as Parkinson's. •Lisa Shafer, PhD, director of Global Research in the Neuromodulation business of Medtronic, Inc., emphasized the importance of industry and physician collaboration to drive the continued development of innovative treatments.

"Patients every day are suffering from conditions such as Parkinson's and Alzheimer's," Dr. Grigsby said. "A lot of years and dollars have been spent on dealing with these neurological cases, and not a single cure has been discovered."

Editor's Note: All expert sources available for comment.

About Neurovations
Napa, Calif.-based Neurovations is a leading clinical research and education company in the pain management and neuroscience fields. The company offers clinical trial management services and a state-of-the-art surgical training facility, also used for investigator training, clinical training, and medical device development projects. Neurovations was founded by Eric Grigsby, MD, MBA, who also leads the Napa Pain Institute, the region's leading pain management and minimally invasive spine treatment center.



For information contact:
Christopher Navalta
Email Contact
(415) 986-7212





Source: Marketwire